Evidence map›Paper›PMID 24798066›Full record

ArticleNMR in biomedicine2014

Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer?

Charles S Springer, Xin Li, Luminita A Tudorica, Karen Y Oh, Nicole Roy, Stephen Y-C Chui, Arpana M Naik, Megan L Holtorf, Aneela Afzal, William D Rooney and 1 more

Abstract read
In one paragraph

Article in NMR in biomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. In vivo methods for imaging blood-brain barrier function and dysfunction.European journal of nuclear medicine and molecular imaging · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Gray matter blood-brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charles S SpringerAdvanced Imaging Research Center, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Xin Li
Luminita A Tudorica
Karen Y Oh
Nicole Roy
Stephen Y-C Chui
Arpana M Naik
Megan L Holtorf
Aneela Afzal
William D Rooney
Wei Huang

Funding

OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
7 Tesla MRI Bolus CR Studies of Human BBB PermeabilityR01NS040801 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROONEY, WILLIAM D, SPRINGER, CHARLES S. · 2001 to 2013
$3.6M
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer TherapyU01CA154602 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HUANG, WEI, RYAN, CHRISTOPHER WALTER · 2011 to 2015
$2.9M
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer DiagnosisR44CA180425 · NCI · IMBIO, LLC · PI KEITH, LAUREN · 2013 to 2016
$1.8M
Shutter-Speed DCE-MRI Discrimination of Benign and Malignant Breast DiseaseR01CA120861 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HUANG, WEI · 2007 to 2009
$928k
Research-Dedicated PACS Server for the OHSU Advanced Imaging Research CenterS10RR027694 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARBARA, THOMAS MICHAEL · 2010 to 2010
$102k
NCATS NIH HHS UL1 TR000128NCI NIH HHS R01 CA120861NCI NIH HHS R44 CA180425NCI NIH HHS U01 CA154602NCI NIH HHS UO1 CA154602NCRR NIH HHS S10 RR027694NCRR NIH HHS UL1 RR024140NINDS NIH HHS R01 NS040801
6 · The paper itself

Abstract

Shutter-speed pharmacokinetic analysis of dynamic-contrast-enhanced (DCE)-MRI data allows evaluation of equilibrium inter-compartmental water interchange kinetics. The process measured here - transcytolemmal water exchange - is characterized by the mean intracellular water molecule lifetime (τi). The τi biomarker is a true intensive property not accessible by any formulation of the tracer pharmacokinetic paradigm, which inherently assumes it is effectively zero when applied to DCE-MRI. We present population-averaged in vivo human breast whole tumor τi changes induced by therapy, along with those of other pharmacokinetic parameters. In responding patients, the DCE parameters change significantly after only one neoadjuvant chemotherapy cycle: while K(trans) (measuring mostly contrast agent (CA) extravasation) and kep (CA intravasation rate constant) decrease, τi increases. However, high-resolution, (1 mm)(2), parametric maps exhibit significant intratumor heterogeneity, which is lost by averaging. A typical 400 ms τi value means a trans-membrane water cycling flux of 10(13) H2O molecules s(-1)/cell for a 12 µm diameter cell. Analyses of intratumor variations (and therapy-induced changes) of τi in combination with concomitant changes of ve (extracellular volume fraction) indicate that the former are dominated by alterations of the equilibrium cell membrane water permeability coefficient, PW, not of cell size. These can be interpreted in light of literature results showing that τi changes are dominated by a PW (active) component that reciprocally reflects the membrane driving P-type ATPase ion pump turnover. For mammalian cells, this is the Na(+), K(+)-ATPase pump. These results promise the potential to discriminate metabolic and microenvironmental states of regions within tumors in vivo, and their changes with therapy.

Indexed as

Biomarkers, TumorBreast NeoplasmsCell SizeContrast MediaFemaleHumansIntracellular SpaceKineticsMagnetic Resonance ImagingPermeabilityWaterBiomarkers, TumorContrast MediaWaterheterogeneityintratumormapsmetabolic activitytherapy

Identifiers

PMID24798066
PMCPMC4174415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.